Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Oncol. Dec 10, 2014; 5(5): 858-864
Published online Dec 10, 2014. doi: 10.5306/wjco.v5.i5.858
Published online Dec 10, 2014. doi: 10.5306/wjco.v5.i5.858
Table 1 Baseline characteristics of subjects in studies evaluating response to erlotinib after gefitinib
Ref. | Year | Country | Type of study | No. of patients | Gender (M/F) | Smoking status (smokers/NS) | Histology (A/S/other) |
Garfield[9] | 2005 | United States | Case report | 1 | 1/0 | 1/0 | 0/0/1 |
Viswanathan et al[16] | 2005 | United States | Case report | 5 | 1/4 | 2/3 | NA |
Walther et al[17] | 2006 | United Kingdom | Case report | 1 | 0/1 | 0/1 | 1/0/0 |
Chang et al[18] | 2007 | Taiwan | Case report | 1 | 1/0 | 1/0 | 1/0/0 |
Cho et al[19] | 2007 | South Korea | Prospective | 21 | 10/11 | 10/11 | 16/3/2 |
Gridelli et al[32] | 2007 | Italy | Case report | 3 | 0/3 | 0/3 | 3/0/0 |
Kim et al[33] | 2007 | South Korea | Case report | 1 | 0/1 | 0/1 | 1/0/0 |
Costa et al[23] | 2008 | United States | Retrospective | 18 | 7/11 | 7/11 | 16/0/2 |
Lee et al[21] | 2008 | South Korea | Prospective | 23 | 4/19 | 0/23 | 22/0/1 |
Vasile et al[22] | 2008 | Italy | Prospective | 8 | 4/4 | 1/7 | 6/0/2 |
Wong et al[20] | 2008 | Singapore | Retrospective | 14 | 4/10 | 1/13 | 10/1/3 |
Wong et al[34] | 2008 | Singapore | Case report | 1 | 0/1 | 0/1 | 1/0/0 |
Wu et al[35] | 2008 | Taiwan | Case report | 1 | 0/1 | 0/1 | 1/0/0 |
Katayama et al[36] | 2009 | Japan | Retrospective | 7 | 2/5 | NA | 7/0/0 |
Sim et al[24] | 2009 | South Korea | Retrospective | 16 | 0/16 | 0/16 | 16/0/0 |
Zhou et al[25] | 2009 | China | Prospective | 21 | 14/7 | 10/11 | 8/9/4 |
Wong et al[26] | 2010 | China | Retrospective | 21 | 2/19 | 1/20 | 19/0/2 |
Asami et al[27] | 2011 | Japan | Retrospective | 42 | 13/29 | 14/28 | 42/0/0 |
Hata et al[29] | 2011 | Japan | Retrospective | 125 | 49/76 | 55/70 | 117/NA/8 |
Masuda et al[37] | 2011 | Japan | Case report | 3 | 3/0 | NA | 3/0/0 |
Shoji et al[38] | 2011 | Japan | Case report | 1 | 1/0 | NA | 1/0/0 |
Song et al[39] | 2011 | China | Retrospective | 20 | 9/11 | 5/15 | 18/0/2 |
Takenaka et al[40] | 2011 | Japan | Case report | 1 | 0/1 | 0/1 | 1/0/0 |
Saito et al[41] | 2012 | Japan | Retrospective | 21 | 9/12 | 9/12 | 19/0/2 |
Tetsumoto et al[42] | 2012 | Japan | Case report | 2 | 0/2 | 0/2 | 2/0/0 |
Koyama et al[43] | 2013 | Japan | Retrospective | 1041 | 56/48 | 50/54 | 90/6/8 |
- Citation: Singh N, Jindal A, Behera D. Erlotinib usage after prior treatment with gefitinib in advanced non-small cell lung cancer: A clinical perspective and review of published literature. World J Clin Oncol 2014; 5(5): 858-864
- URL: https://www.wjgnet.com/2218-4333/full/v5/i5/858.htm
- DOI: https://dx.doi.org/10.5306/wjco.v5.i5.858